| Use and content of primary care office-based vs telemedicine care visits during the COVID-19 pandemic in the US GC Alexander, M Tajanlangit, J Heyward, O Mansour, DM Qato, ... JAMA network open 3 (10), e2021476-e2021476, 2020 | 408 | 2020 |
| Coverage of nonpharmacologic treatments for low back pain among US public and private insurers J Heyward, CM Jones, WM Compton, DH Lin, JL Losby, IB Murimi, ... JAMA Network Open 1 (6), e183044-e183044, 2018 | 135 | 2018 |
| Cherry-picking by trialists and meta-analysts can drive conclusions about intervention efficacy E Mayo-Wilson, T Li, N Fusco, L Bertizzolo, JK Canner, T Cowley, P Doshi, ... Journal of clinical epidemiology 91, 95-110, 2017 | 114 | 2017 |
| Association between sodium-glucose cotransporter 2 (SGLT2) inhibitors and lower extremity amputation: a systematic review and meta-analysis J Heyward, O Mansour, L Olson, S Singh, GC Alexander PLoS One 15 (6), e0234065, 2020 | 70 | 2020 |
| Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015–2017: a cross-sectional study TJ Moore, J Heyward, G Anderson, GC Alexander BMJ open 10 (6), e038863, 2020 | 67 | 2020 |
| Prescription drug coverage for treatment of low back pain among US Medicaid, Medicare Advantage, and commercial insurers DH Lin, CM Jones, WM Compton, J Heyward, JL Losby, IB Murimi, ... JAMA network open 1 (2), e180235-e180235, 2018 | 60 | 2018 |
| National Trends in Use of Sodium‐Glucose Cotransporter‐2 Inhibitors and Glucagon‐like Peptide‐1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020 R Adhikari, K Jha, Z Dardari, J Heyward, RS Blumenthal, RH Eckel, ... Journal of the American Heart Association 11 (9), e023811, 2022 | 50 | 2022 |
| Harms are assessed inconsistently and reported inadequately Part 1: Systematic adverse events E Mayo-Wilson, N Fusco, T Li, H Hong, JK Canner, K Dickersin, ... Journal of clinical epidemiology 113, 20-27, 2019 | 43 | 2019 |
| Assessment of the FDA risk evaluation and mitigation strategy for transmucosal immediate-release fentanyl products JE Rollman, J Heyward, L Olson, P Lurie, J Sharfstein, GC Alexander JAMA 321 (7), 676-685, 2019 | 42 | 2019 |
| Harms are assessed inconsistently and reported inadequately Part 2: Nonsystematic adverse events E Mayo-Wilson, N Fusco, T Li, H Hong, JK Canner, K Dickersin, ... Journal of clinical epidemiology 113, 11-19, 2019 | 38 | 2019 |
| Clinical trial registration and reporting: a survey of academic organizations in the United States E Mayo-Wilson, J Heyward, A Keyes, J Reynolds, S White, N Atri, ... BMC medicine 16 (1), 1-13, 2018 | 36 | 2018 |
| Evaluation of the extended-release/long-acting opioid prescribing risk evaluation and mitigation strategy program by the US Food and Drug Administration: a review J Heyward, L Olson, JM Sharfstein, EA Stuart, P Lurie, GC Alexander JAMA internal medicine 180 (2), 301-309, 2020 | 33 | 2020 |
| Lower use of biologics for the treatment of asthma in publicly insured individuals AT Akenroye, J Heyward, C Keet, GC Alexander The Journal of Allergy and Clinical Immunology: In Practice 9 (11), 3969-3976, 2021 | 32 | 2021 |
| Telemedicine and office-based care for behavioral and psychiatric conditions during the COVID-19 pandemic in the United States O Mansour, M Tajanlangit, J Heyward, R Mojtabai, GC Alexander Annals of internal medicine 174 (3), 428-430, 2021 | 29 | 2021 |
| Primary care physicians’ preparedness to treat opioid use disorder in the United States: A cross-sectional survey K Foti, J Heyward, M Tajanlangit, K Meek, C Jones, A Kolodny, ... Drug and alcohol dependence 225, 108811, 2021 | 26 | 2021 |
| Integrating multiple data sources (MUDS) for meta-analysis to improve patient-centered outcomes research: a protocol for a systematic review E Mayo-Wilson, S Hutfless, T Li, G Gresham, N Fusco, J Ehmsen, ... Systematic reviews 4 (1), 1-28, 2015 | 18 | 2015 |
| Setting priorities for diabetic retinopathy clinical research and identifying evidence gaps JT Le, S Hutfless, T Li, NM Bressler, J Heyward, AK Bittner, A Glassman, ... Ophthalmology Retina 1 (2), 94-102, 2017 | 17 | 2017 |
| Trends in Insulin Types and Devices Used by Adults With Type 2 Diabetes in the United States, 2016 to 2020 S Sarkar, J Heyward, GC Alexander, RR Kalyani JAMA Network Open 4 (10), e2128782-e2128782, 2021 | 16 | 2021 |
| National Clinical Trials Registration and Results Reporting Taskforce Survey Subcommittee. Clinical trial registration and reporting: a survey of academic organizations in the … E Mayo-Wilson, J Heyward, A Keyes, J Reynolds, S White, N Atri, ... BMC Med 16 (1), 60, 2018 | 15 | 2018 |
| Ambulatory noninsulin treatment of type 2 diabetes mellitus in the United States, 2015 to 2019 J Heyward, J Christopher, S Sarkar, JI Shin, RR Kalyani, GC Alexander Diabetes, Obesity and Metabolism 23 (8), 1843-1850, 2021 | 12 | 2021 |
